Back to Superinvestors
SUPERINVESTOR HOLDERS
OGN
Organon & Co
Healthcare · Drug Manufacturers - General
- Holders
- 5
- Total value
- $78,005,539
- Total shares
- 5,764,798
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Thomas Kahn
Kahn Brothers Group
|
2,670,523 | $36,158,881 | 5.71% | REDUCE -2,866,470 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
1,245,588 | $16,815,436 | 0.01% | REDUCE -2,205,038 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
1,032,313 | $13,977,518 | 0.03% | REDUCE -224,742 | 30 Jun 2026 |
|
Charles Brandes
Brandes Investment Partners, LP
|
729,502 | $9,877,457 | 0.07% | ADD +37,877 | 30 Jun 2026 |
|
Mario Gabelli
GAMCO Investors
|
86,872 | $1,176,247 | 0.01% | NEW +86,872 | 30 Jun 2026 |